Trading Halt Active
This ticker is currently halted. Check the Halts tab for details.
Volatility Alert
This ticker is experiencing unusual price movement.
Key Stats
Day Range
$85.81
$88.90
52-Week Range
$69.81
$148.83
14-Day RSI
-
Upcoming Earnings
---
---
Volume
-
Analyst Rating
-
-
-
-
Price Target
-
-
Last Earnings
-
-
About
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Valuation
7.58B
Market Cap
-
Forward P/E
-
Trailing P/E
-
Price/Book
-
EPS (TTM)
Financial Snapshot
-
Revenue (TTM)
-
EBITDA
-
Free CF
-
Total Debt
-
Beta
Margins & Dividends
-
Gross Margin
-
Op. Margin
-
Div Rate
-
Div Yield
-
Ex-Div Date
Profile
-
Sector
-
Industry
-
Short % Float
Nearest Expiry:
Loading...
Max Pain:
$0.00
Support (Put Wall)
$0.00
OI: 0
Current Price
$0.00
Resistance (Call Wall)
$0.00
OI: 0
Calls
Loading...
Puts
Loading...
Unusual Whale Flow
Loading anomaly scanner...
Experimental. Executive-branch trades are sourced from a third-party aggregator (open-cabinet.org) that parses OGE filings — not yet independently verified. Most executive-branch filings are bonds; only trades resolved to an equity ticker appear here.